Papers
1
Total Citations
12
H-Index
1
About
Chenxi Song is a pioneering interventional cardiologist whose research focuses on advancing robotic-assisted percutaneous coronary intervention (PCI) and optimizing cardiovascular outcomes. Dr. Song’s major contribution lies in demonstrating the feasibility and safety of robotic PCI in China, highlighted by the landmark study “Feasibility and safety of robotic PCI in China: first in man experience in Asia” (2019, 12 citations). This work established the first Asian clinical evidence for a second-generation robotic system, showing its potential to enhance procedural precision, reduce radiation exposure, and improve lesion measurement accuracy—key steps toward broader adoption of robotic technology in interventional cardiology. Beyond this, Dr. Song’s research explores innovative strategies to refine coronary interventions, with a focus on patient safety and procedural efficiency. While citation counts are modest, the work’s significance as a foundational Asian study underscores its impact on regional clinical practice. Dr. Song’s achievements include being at the forefront of introducing robotic PCI to China, paving the way for future studies and training programs. For students and researchers, Dr. Song exemplifies how early-stage innovation can drive transformative change in cardiovascular medicine, blending technical skill with a commitment to advancing minimally invasive care.
Research Focus
Key Achievements
Top Papers
- 1